Document Detail

Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker.
MedLine Citation:
PMID:  21315119     Owner:  NLM     Status:  Publisher    
Polylysine dendrimers have potential as biodegradable vectors for the delivery of cytotoxic drugs to solid tumours. Here, the cytotoxicity, drug release and tumour targeting properties of Generation 5 PEGylated polylysine dendrimers comprising an outer generation of L-lysine or succinimyldipropyldiamine (SPN) and containing doxorubicin (DOX) linked through an acid labile 4-(hydrazinosulfonyl) benzoic acid (HSBA) linker have been characterised. Less than 10% of the DOX load was released from LYS or SPN dendrimers in pH 7.4 buffer over 3days. In contrast approximately 100% release was evident at pH 5. The DOX-conjugated dendrimers also retained similar cytotoxic properties to free DOX in in vitro cell culture studies (presumably as a result of in situ liberation of free DOX). The clearance patterns of the DOX conjugated SPN and all-lysine dendrimers were similar to the equivalent non-DOX conjugated systems, however the SPN dendrimers showed reduced metabolic lability and increased uptake into RES organs when compared to the equivalent all-lysine dendrimers. In vivo assessment of the DOX-conjugated, PEGylated polylysine dendrimers (both SPN and LYS constructs) in rats bearing Walker 256 tumours revealed higher uptake into tumour tissue when compared with control tissue such as muscle (~8 fold) and heart (~3 fold). The data suggest that polylysine dendrimers containing DOX conjugated via an acid labile HSBA linker may provide a mechanism to target the delivery of DOX to tumours.
Lisa M Kaminskas; Brian D Kelly; Victoria M McLeod; Gian Sberna; David J Owen; Ben J Boyd; Christopher J H Porter
Related Documents :
16341939 - Effects of mitochondrial toxins on the brain amino acid concentrations.
12358729 - Role of blood-brain barrier organic anion transporter 3 (oat3) in the efflux of indoxyl...
10930569 - Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice.
12241009 - Mechanisms of hyperammonemia.
916829 - Chain length specificity in the utilization of long chain alcohols for ether lipid bios...
22884629 - Characterization of brevetoxin metabolism in karenia brevis bloom-exposed clams (mercen...
3113799 - Pepsinogens, pepsins, and peptic ulcer.
2451579 - Clinical significance of tartrate-sensitive and tartrate-resistant acid phosphatase ind...
19397979 - Mechanisms of antihyperuricemic effect of phyllanthus niruri and its lignan constituents.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-8
Journal Detail:
Title:  Journal of controlled release : official journal of the Controlled Release Society     Volume:  -     ISSN:  1873-4995     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607908     Medline TA:  J Control Release     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010. Published by Elsevier B.V.
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville campus), 381 Royal Pde, Parkville, VIC, 3052, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bone reservoir: Injectable hyaluronic acid hydrogel for minimal invasive bone augmentation.
Next Document:  Selective gene transfection of individual cells in vitro with plasmonic nanobubbles.